Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2014

Nov 17, 2014

34129_dirs_2014-11-17_2d71309a-3a05-477b-84e1-eda54d387925.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2014-11-14

Reporting Person: Stein Kathryn E (Senior VP, Prd Dev & Reg Aff)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-14 Common Stock M 23211 $0.94 Acquired 66416 Direct
2014-11-14 Common Stock S 23211 $23.33 Disposed 43205 Direct
2014-11-17 Common Stock M 2090 $.94 Acquired 45295 Direct
2014-11-17 Common Stock S 2090 $22.95 Disposed 43205 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-14 Stock Option (right to buy) $0.94 M 23211 Disposed 2017-01-06 Common Stock (23211) Direct
2014-11-17 Stock Option (right to buy) $0.94 M 2090 Disposed 2017-01-06 Common Stock (2090) Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on 6/30/2014.

F2: The price reported in Column 4 is a weighted average price.